Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BGI Genomics Co., Ltd. (300676.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
53.60-0.93 (-1.71%)
At close: 03:04PM CST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close54.53
Open54.52
Bid53.66 x 0
Ask53.67 x 0
Day's Range53.13 - 54.77
52 Week Range53.13 - 105.66
Volume1,824,797
Avg. Volume2,886,042
Market Cap22.186B
Beta (5Y Monthly)0.38
PE Ratio (TTM)22.52
EPS (TTM)2.38
Earnings DateApr 28, 2022 - Apr 29, 2022
Forward Dividend & Yield0.35 (0.65%)
Ex-Dividend DateJul 06, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 300676.SZ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      WHO visit photos unveiled - BGI Genomics supports post-pandemic recovery in Hong Kong

      World Health Organization (WHO) has recently unveiled photos from its Feb-Mar 2021 visit to Hong Kong as COVID-19 affected the city, covering community testing facilities in key locations such as the Hong Kong International Airport and the Morse Park Sports Centre.

    • Reuters

      Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case

      A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese genomics company BGI Group after finding that Illumina's DNA-sequencing systems infringed two patents. The jury also said Illumina infringed the patents willfully, and that three patents it had accused BGI's Complete Genomics unit of infringing were invalid.

    • Reuters

      Illumina ordered to pay Chinese company $333 million in gene-sequencing patent case

      A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese genetic analysis company BGI Genomics after finding that Illumina's DNA-sequencing systems infringed two patents. The jury also said https://tmsnrt.rs/39K62Cz Illumina infringed the patents willfully, and that three patents it had accused BGI's Complete Genomics unit of infringing were invalid. BGI and Illumina have been embroiled in a global legal battle over their respective sequencing technologies.

    Advertisement
    Advertisement